En español
NIDA

Menu

Blending Addiction Science and Treatment: The Impact of Evidence-Based Practices on Individuals, Families and Communities

Revised June 2012

2008 Meeting Overview:

This unique two-day conference held June 2-3, 2008 in Cincinnati, Ohio was the seventh in the series of Blending Conferences held since 2000.  Through a series of lectures and workshops, clinicians and researchers were provided an opportunity to examine cutting edge approaches for treating and preventing drug abuse and addiction.  These scientific advances ranged from the latest findings on the role of genetics to the Blending Team products addressing motivational interviewing, buprenorphine, and motivational incentives all aimed at helping prevent former drug users from relapsing.

The conference format included four presentations, along with the Eileen Pencer Memorial Lecture delivered this year by Dr. Denise Carise.  A total of 24 breakout sessions were conducted as well.

Goals and Objectives:

The goal of the Blending Addiction Science and Treatment Conference was to make the best drug abuse and addiction treatments available to those who need them.

Upon completion of the conference participants were able to:

  • Employ bi-directional communication to advance the exchange of ideas among drug abuse and addiction researchers and community treatment providers.
  • Recognize research conducted by the National Institute on Drug Abuse (NIDA) and its role in the development of science-based practices.
  • Identify Blending Team Products and discuss how they may be utilized in the treatment of drug abuse and addictive disorders.
  • Cite additional resources for knowledge and skill development of science-based practices.
  • Discuss and disseminate science-based practices for the treatment of drug abuse and addictive disorders.

Attendance:

Over 1100 individuals registered to attend the 2008 NIDA Blending Conference, with 809 participants requesting Continuing Medical Education (CME) and Continuing Education Units (CEU). Attendees documented their satisfaction with the experience, adding that the Blending Conference provided a unique opportunity to network with leaders, researchers, and other addiction professionals.  Further feedback reported:

  • Nearly 75% respondents indicated that they intended to change their clinical practice as a result of attending the Blending Conference.
  • 99% indicated that they would recommend a colleague to attend a future NIDA Blending Conference.

Agendas:

Meeting Day 1

Begin End Session Faculty
7:00 a.m. 8:30 a.m. Registration
8:30 a.m. 9:00 a.m. Opening Remarks Timothy P. Condon, Ph.D.
Eugene Somoza, M.D., Ph.D.
9:00 a.m. 10:00 a.m. Co-Occurring Psychiatric and Substance use Disorders: The Role of Stress Kathleen T. Brady, M.D., Ph.D.
10:00 a.m. 11:00 a.m. Addiction and the Family: Challenges for Providers, the Patients, and Families Dennis C. Daley, Ph.D.
11:00 a.m. 11:15 a.m. Break
11:15 a.m. 12:45 p.m. Morning Breakout Sessions
Why, When and How to Help Substance Abusers Stop Smoking Gregory S. Brigham, Ph.D.
Robert M. Anthenelli, M.D.
Pharmacotherapy for Cocaine Dependence: Do We Know Enough to Prescribe in the “Real World”? Jeffrey Selzer, M.D.
Charles P. O'Brien, M.D., Ph.D.
Medical Conditions and Substance Abuse Frances Campbell, Ph.D.
Glenn J. Treisman, M.D., Ph.D.
Managing Substance Abuse Disorders in Primary Care Settings Oscar G. Bukstein, M.D., M.P.H.
Jennifer G. Smith, M.D.
Seth G. Eisenberg, M.D.
Evidence for 12-Step Facilitation Therapy Dennis M. Donovan, Ph.D.
Mimmie H. Byrne, LICSW, CAC
Juvenile Justice: The Reclaiming Futures Project Laura Burney Nissen, Ph.D., M.S.W.
The Honorable Anthony Capizzi, J.D.
12:45 p.m 2:30 p.m. Afternoon Presentation A.Thomas McLellan, Ph.D.
2:30 p.m. 2:45 p.m. Break
2:45 p.m. 4:00 p.m. Afternoon Breakout Sessions
Understanding and Utilizing Buprenorphine in the Treatment and Short Term Detox of Opioid Addiction Thomas E. Freese, Ph.D.
Mary Ann Detmer, L.P.N.
Gregory Brigham, Ph.D.
Promoting Awareness of Motivational Incentives John Hamilton, LMFT, LADC
Maxine Stitzer, Ph.D.
Amy Shanahan, M.S., CAC, CASAC
Long Term Recovery Management James R. McKay, Ph.D.
Michael T. Flaherty, Ph.D.
Thomas A. Kirk, Jr., Ph.D.
Integrating Evidence-Based Practice and Community Treatment Centers Lonnetta Albright
Dean L. Babcock, M.S.W., ACSW, LCSW
D. Dwayne Simpson, Ph.D.
Motivational Interventions for Special Populations Antoine Douaihy, M.D.
Kathleen M. Carroll, Ph.D.
José Szapocznik, Ph.D
Traumatic Brain Injury and Substance Abuse John D. Corrigan, Ph.D., ABPP
Gregory O'Shanick, M.D.
4:00 p.m. 4:15 p.m. Break
4:15 p.m. 5:30 p.m. Afternoon Breakout Sessions Continue

Meeting Day 2

Begin End Session Faculty
7:00 a.m. 8:30 a.m.  Registration
9:00 a.m. 10:30 a.m. Addiction and the Brain Nora D. Volkow, M.D.
10:30 a.m. 11:00 a.m. Strategies to Decrease Substance Abuse Bertha Madras, Ph.D.
11:00 a.m. 11:15 a.m. Break
11:15 a.m. 12:45 p.m. Morning Breakout Sessions
Addiction Treatments of the Future: The Role of Genetics Mary Jeanne Kreek, M.D.
Louise Haynes, M.S.W.
Allan J. Cohen, M.A., MFT
Pain Management for Substance Abusing Clients Eugene Somoza, M.D., Ph.D.
Seddon R. Savage, M.D., M.S.
Evidence-Based Practice Update-Psychosocial Intervention Joan E. Zweben, Ph.D.
Maxine Stitzer, Ph.D.
Integrating Smoking Cessation in Substance Abuse Treatment Joseph R. Guydish, Ph.D., M.P.H.
Carl Rollyn Sullivan, M.D.
Steven Kipnis, M.D., FACP, FASAM
Strong African American Families (SAAF) Program: The Science and Implementation Approach Gene H. Brody, Ph.D.
Christina M. Grange, Ph.D.
Implementation of Contingency Management within two NYC Methadone Programs Scott Kellogg, Ph.D.
Susan L. Brandau, CASAC
12:45 p.m. 2:30 p.m. Eileen Pencer Memorial Lecture: The Power of Science and the Practice of Treatment Denise Carise, Ph.D.
2:30 p.m. 2:45 p.m. Break
2:45 p.m. 4:00 p.m. Afternoon Breakout Sessions
Motivational Interviewing Assessment: Supervisor Training for Enhanced Proficiency Steve Martino, Ph.D.
Christiane Farentinos, M.D., M.P.H., CADC II, NCDC II
Steven L. Gallon, Ph.D.
Challenges in Determining and Implementing Best Practices in Criminal Justice Carl G. Leukefeld, D.S.W.
Melanie Heaps
Howard A. Liddle, Ed.D.
Women and Substance Abuse Treatment Shelly F. Greenfield, M.D., M.P.H.
Theresa Winhusen, Ph.D.
Ann Uhler, M.A.
HIV and Substance Use Disorders David S. Metzger, Ph.D.
Antoine Douaihy, M.D.
Lisa R. Metsch, Ph.D.
State of the Science in Adolescent Substance Abuse Treatment Michael L. Dennis, Ph.D.
Paula D. Riggs, M.D.
Alan J. Budney, Ph.D.
CRAFT: An Evidence-Based Practice for Engaging Resistant Substance Users Raymond Anderson, Ph.D., LPCC, LADAC
Kimberly C. Kirby, Ph.D.
4:00 p.m. 4:15 p.m. Break
4:15 p.m. 5:30 p.m. Afternoon Breakout Sessions Continue

 

This page was last updated June 2012

    National Drug Abuse Treatment Clinical Trials Network: Search listings of drug abuse clinical trials, click here

    Looking for Treatment?

    Use the SAMHSA Treatment Locator or 1-800-662-HELP.